Tender Details

Country: Nigeria
Summary: Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector
NGT Ref No: 68148393
Deadline: 22 Jul 2022
Financier: World Bank (WB)
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: GDS-RFB-01-2022
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Tenders are invited for Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector 1 Medicines for Lassa Fever treatment 2 Medicines for post exposure prophylaxis 3 Medicines for Cholera and Meningitis 4 General Personnel Protective Equipment (PPE) 5 Medical consumables for infection and prevention 6 Medial consumables for investigation Bid security: At least 3% of Bid price Bidding will be conducted through, open, National competitive Procurement using a request for Bids (RFB) as specified in the World Bank-s “Procurement Regulations for IPF Borrowers” July 2016, revised November 1, 2017 and August 1, 2018 and is open to all eligible bidders as defined in the procurement Regulation. Interested bidders may obtain further information from the Nigerian Centre for Disease Control, Regional Disease Surveillance Systems Enhancement Project (REDISSE II), Mr. Marcel N, D-A, Email: marel.dibang@ncdc.gon.ng and inspect the biding document during office hours from 0900 to 1700 hours local time at the address give below. Qualification requirements include: • Documentary evidence of two contracts of similar nature and magnitude during the last five (50 years • Valid and up to date certifications with FIRS (tax Clearance), NSITF,PENCOM, ITF & BPP • Audited financial statement for the last three (3) years i.e. 2019, 2020 & 2021 to demonstrate the financial capability of the Bidder in terms of profitability and adequate working capital. • A manufacturer-s Authorization/NAFDAC registration certificate that has NAFDAC number for Ribavirin not produced by the company. Additional details are provided in the bidding documents.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector - Nigeria Tender

The NIGERIA CENTRE FOR DISEASE CONTROL (NCDC), a Government sector organization in Nigeria, has announced a new tender for Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector. This tender is published on NigeriaTenders under NGT Ref No: 68148393 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-07-22.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.